4077F Doc t-pa administration considered
Other
Also known as: tPA consideration, thrombolytic consideration
Performance measure indicating documentation that tissue plasminogen activator (tPA) administration was considered for stroke treatment. Tracks decision-making documentation.
Clinical Context
Quality measure for acute ischemic stroke care. Documents appropriate evaluation and consideration of thrombolytic therapy within treatment window.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.